Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Patient reported outcomes more important than objective inflammatory markers for sick leave in biologics-treated rheumatoid arthritis patients.

Olofsson T, Söderling JK, Gülfe A, Kristensen LE, Wallman JK.

Arthritis Care Res (Hoboken). 2018 Jun 8. doi: 10.1002/acr.23619. [Epub ahead of print]

PMID:
29885037
2.

A Total Bounded Variation Approach to Low Visibility Estimation on Expressways

Cheng X, Yang B, Liu G, Olofsson T, Li H.

Sensors (Basel). 2018 Jan 29;18(2). pii: E392. doi: 10.3390/s18020392.

3.

Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial.

Mårtensson A, Abolhalaj M, Lindstedt M, Mårtensson A, Olofsson TC, Vásquez A, Greiff L, Cervin A.

Laryngoscope Investig Otolaryngol. 2017 Nov 8;2(6):410-416. doi: 10.1002/lio2.93. eCollection 2017 Dec.

4.

Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth.

Spyrou A, Kundu S, Haseeb L, Yu D, Olofsson T, Dredge K, Hammond E, Barash U, Vlodavsky I, Forsberg-Nilsson K.

Mol Cancer Ther. 2017 Aug;16(8):1705-1716. doi: 10.1158/1535-7163.MCT-16-0900. Epub 2017 Jul 17.

PMID:
28716813
5.

Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.

Jiang Y, Marinescu VD, Xie Y, Jarvius M, Maturi NP, Haglund C, Olofsson S, Lindberg N, Olofsson T, Leijonmarck C, Hesselager G, Alafuzoff I, Fryknäs M, Larsson R, Nelander S, Uhrbom L.

Cell Rep. 2017 May 2;19(5):1080-1081. doi: 10.1016/j.celrep.2017.04.053. No abstract available.

6.

Improvement of identification methods for honeybee specific Lactic Acid Bacteria; future approaches.

Lamei S, Hu YO, Olofsson TC, Andersson AF, Forsgren E, Vásquez A.

PLoS One. 2017 Mar 27;12(3):e0174614. doi: 10.1371/journal.pone.0174614. eCollection 2017.

7.

Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.

Jiang Y, Marinescu VD, Xie Y, Jarvius M, Maturi NP, Haglund C, Olofsson S, Lindberg N, Olofsson T, Leijonmarck C, Hesselager G, Alafuzoff I, Fryknäs M, Larsson R, Nelander S, Uhrbom L.

Cell Rep. 2017 Jan 24;18(4):977-990. doi: 10.1016/j.celrep.2017.01.003. Erratum in: Cell Rep. 2017 May 2;19(5):1080-1081.

8.

Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?

Olofsson T, Petersson IF, Eriksson JK, Englund M, Nilsson JA, Geborek P, Jacobsson LTH, Askling J, Neovius M; ARTIS Study Group.

Ann Rheum Dis. 2017 Jul;76(7):1245-1252. doi: 10.1136/annrheumdis-2016-210239. Epub 2017 Jan 10.

PMID:
28073801
9.

Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden.

Wallman JK, Jöud A, Olofsson T, Jacobsson LTH, Bliddal H, Kristensen LE.

Rheumatology (Oxford). 2017 May 1;56(5):716-724. doi: 10.1093/rheumatology/kew473.

PMID:
28064208
10.

Fighting Off Wound Pathogens in Horses with Honeybee Lactic Acid Bacteria.

Olofsson TC, Butler É, Lindholm C, Nilson B, Michanek P, Vásquez A.

Curr Microbiol. 2016 Oct;73(4):463-73. doi: 10.1007/s00284-016-1080-2. Epub 2016 Jun 21.

11.

Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.

Wallman JK, Eriksson JK, Nilsson JÅ, Olofsson T, Kristensen LE, Neovius M, Geborek P.

J Rheumatol. 2016 Jul;43(7):1292-9. doi: 10.3899/jrheum.150617. Epub 2016 Jun 1.

PMID:
27252420
12.

Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers.

Mårtensson A, Greiff L, Lamei SS, Lindstedt M, Olofsson TC, Vasquez A, Cervin A.

Int Forum Allergy Rhinol. 2016 Sep;6(9):956-63. doi: 10.1002/alr.21762. Epub 2016 Apr 15.

PMID:
27080343
13.

Short communication: Lactic acid bacteria from the honeybee inhibit the in vitro growth of mastitis pathogens.

Piccart K, Vásquez A, Piepers S, De Vliegher S, Olofsson TC.

J Dairy Sci. 2016 Apr;99(4):2940-2944. doi: 10.3168/jds.2015-10208. Epub 2016 Jan 29.

PMID:
26830735
14.

Does disease activity at start of biologic therapy influence work-loss in RA patients?

Olofsson T, Johansson K, Eriksson JK, van Vollenhoven R, Miller H, Petersson IF, Askling J, Neovius M.

Rheumatology (Oxford). 2016 Apr;55(4):729-34. doi: 10.1093/rheumatology/kev407. Epub 2015 Dec 18.

PMID:
26683196
15.

Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas.

Zhang L, Kundu S, Feenstra T, Li X, Jin C, Laaniste L, El Hassan TE, Ohlin KE, Yu D, Olofsson T, Olsson AK, Pontén F, Magnusson PU, Nilsson KF, Essand M, Smits A, Dieterich LC, Dimberg A.

Sci Signal. 2015 Dec 8;8(406):ra125. doi: 10.1126/scisignal.aaa1690.

PMID:
26645582
16.

Functionally Structured Genomes in Lactobacillus kunkeei Colonizing the Honey Crop and Food Products of Honeybees and Stingless Bees.

Tamarit D, Ellegaard KM, Wikander J, Olofsson T, Vásquez A, Andersson SG.

Genome Biol Evol. 2015 May 6;7(6):1455-73. doi: 10.1093/gbe/evv079.

17.

Extensive intra-phylotype diversity in lactobacilli and bifidobacteria from the honeybee gut.

Ellegaard KM, Tamarit D, Javelind E, Olofsson TC, Andersson SG, Vásquez A.

BMC Genomics. 2015 Apr 11;16:284. doi: 10.1186/s12864-015-1476-6.

18.

Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.

Lindberg N, Jiang Y, Xie Y, Bolouri H, Kastemar M, Olofsson T, Holland EC, Uhrbom L.

J Neurosci. 2014 Oct 29;34(44):14644-51. doi: 10.1523/JNEUROSCI.2977-14.2014.

19.

A pilot study investigating lactic acid bacterial symbionts from the honeybee in inhibiting human chronic wound pathogens.

Butler É, Oien RF, Lindholm C, Olofsson TC, Nilson B, Vásquez A.

Int Wound J. 2016 Oct;13(5):729-37. doi: 10.1111/iwj.12360. Epub 2014 Sep 8.

PMID:
25196349
20.

Lactic acid bacterial symbionts in honeybees - an unknown key to honey's antimicrobial and therapeutic activities.

Olofsson TC, Butler È, Markowicz P, Lindholm C, Larsson L, Vásquez A.

Int Wound J. 2016 Oct;13(5):668-79. doi: 10.1111/iwj.12345. Epub 2014 Sep 8.

PMID:
25195876
22.

Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation.

Rönnerblad M, Andersson R, Olofsson T, Douagi I, Karimi M, Lehmann S, Hoof I, de Hoon M, Itoh M, Nagao-Sato S, Kawaji H, Lassmann T, Carninci P, Hayashizaki Y, Forrest AR, Sandelin A, Ekwall K, Arner E, Lennartsson A; FANTOM consortium.

Blood. 2014 Apr 24;123(17):e79-89. doi: 10.1182/blood-2013-02-482893. Epub 2014 Mar 26.

23.

The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ.

Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird TD, Nochlin D, Schellenberg GD, Brundin R, Olofsson T, Soliymani R, Baumann M, Wirths O, Bayer TA, Nilsson LN, Basun H, Lannfelt L, Ingelsson M.

Acta Neuropathol Commun. 2013 Sep 10;1:60. doi: 10.1186/2051-5960-1-60.

24.

Proteins of novel lactic acid bacteria from Apis mellifera mellifera: an insight into the production of known extra-cellular proteins during microbial stress.

Butler È, Alsterfjord M, Olofsson TC, Karlsson C, Malmström J, Vásquez A.

BMC Microbiol. 2013 Oct 22;13:235. doi: 10.1186/1471-2180-13-235.

25.

Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.

Vidovic K, Ullmark T, Rosberg B, Lennartsson A, Olofsson T, Nilsson B, Gullberg U.

Leuk Res. 2013 Oct;37(10):1341-9. doi: 10.1016/j.leukres.2013.06.018. Epub 2013 Jul 19.

PMID:
23871158
26.

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.

Olofsson T, Petersson IF, Eriksson JK, Englund M, Simard JF, Nilsson JÅ, Geborek P, Jacobsson LT, Askling J, Neovius M.

Ann Rheum Dis. 2014 May;73(5):845-53. doi: 10.1136/annrheumdis-2012-202911. Epub 2013 Mar 21.

PMID:
23520035
27.

Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.

Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H; Nordic CML Study Group (NCMLSG).

Leukemia. 2013 Jul;27(7):1520-6. doi: 10.1038/leu.2013.19. Epub 2013 Jan 18.

PMID:
23328954
28.

The radical-binding lipocalin A1M binds to a Complex I subunit and protects mitochondrial structure and function.

Olsson MG, Rosenlöf LW, Kotarsky H, Olofsson T, Leanderson T, Mörgelin M, Fellman V, Åkerström B.

Antioxid Redox Signal. 2013 Jun 1;18(16):2017-28. doi: 10.1089/ars.2012.4658. Epub 2013 Jan 4.

PMID:
23157686
29.

Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization.

Dieterich LC, Mellberg S, Langenkamp E, Zhang L, Zieba A, Salomäki H, Teichert M, Huang H, Edqvist PH, Kraus T, Augustin HG, Olofsson T, Larsson E, Söderberg O, Molema G, Pontén F, Georgii-Hemming P, Alafuzoff I, Dimberg A.

J Pathol. 2012 Nov;228(3):378-90. doi: 10.1002/path.4072. Epub 2012 Aug 31.

PMID:
22786655
30.

The p53 target gene TRIM22 directly or indirectly interacts with the translation initiation factor eIF4E and inhibits the binding of eIF4E to eIF4G.

Petersson J, Ageberg M, Sandén C, Olofsson T, Gullberg U, Drott K.

Biol Cell. 2012 Aug;104(8):462-75. doi: 10.1111/boc.201100099. Epub 2012 May 31.

PMID:
22509910
31.

Symbionts as major modulators of insect health: lactic acid bacteria and honeybees.

Vásquez A, Forsgren E, Fries I, Paxton RJ, Flaberg E, Szekely L, Olofsson TC.

PLoS One. 2012;7(3):e33188. doi: 10.1371/journal.pone.0033188. Epub 2012 Mar 12.

32.

Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development.

Wallgard E, Nitzsche A, Larsson J, Guo X, Dieterich LC, Dimberg A, Olofsson T, Pontén FC, Mäkinen T, Kalén M, Hellström M.

Dev Dyn. 2012 Apr;241(4):770-86. doi: 10.1002/dvdy.23753. Epub 2012 Feb 21.

33.

Tumor-initiating cells in childhood neuroblastoma--letter.

Mohlin S, Pietras A, Wigerup C, Ora I, Andäng M, Nilsson K, Olofsson T, Gisselsson D, Påhlman S.

Cancer Res. 2012 Feb 1;72(3):821-2; author reply 823. doi: 10.1158/0008-5472.CAN-11-1761. No abstract available.

34.

The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.

Philipson O, Lord A, Lalowski M, Soliymani R, Baumann M, Thyberg J, Bogdanovic N, Olofsson T, Tjernberg LO, Ingelsson M, Lannfelt L, Kalimo H, Nilsson LN.

Neurobiol Aging. 2012 May;33(5):1010.e1-13. doi: 10.1016/j.neurobiolaging.2011.10.022. Epub 2011 Nov 26.

PMID:
22118948
35.

Synthetic aperture focusing of ultrasonic data from multilayered media using an omega-k algorithm.

Skjelvareid MH, Olofsson T, Birkelund Y, Larsen Y.

IEEE Trans Ultrason Ferroelectr Freq Control. 2011 May;58(5):1037-48. doi: 10.1109/TUFFC.2011.1904.

PMID:
21622059
36.

PROX1 is a predictor of survival for gliomas WHO grade II.

Elsir T, Qu M, Berntsson SG, Orrego A, Olofsson T, Lindström MS, Nistér M, von Deimling A, Hartmann C, Ribom D, Smits A.

Br J Cancer. 2011 May 24;104(11):1747-54. doi: 10.1038/bjc.2011.162. Epub 2011 May 10.

37.

Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.

Thörn I, Forestier E, Botling J, Thuresson B, Wasslavik C, Björklund E, Li A, Lindström-Eriksson E, Malec M, Grönlund E, Torikka K, Heldrup J, Abrahamsson J, Behrendtz M, Söderhäll S, Jacobsson S, Olofsson T, Porwit A, Lönnerholm G, Rosenquist R, Sundström C.

Br J Haematol. 2011 Mar;152(6):743-53. doi: 10.1111/j.1365-2141.2010.08456.x. Epub 2011 Jan 20.

PMID:
21250970
38.

t(9;11)(p22;p15) [NUP98/PSIP1] is a poor prognostic marker associated with de novo acute myeloid leukaemia expressing both mature and immature surface antigens.

Lundin C, Horvat A, Karlsson K, Olofsson T, Paulsson K, Johansson B.

Leuk Res. 2011 Jun;35(6):e75-6. doi: 10.1016/j.leukres.2010.11.022. Epub 2010 Dec 17. No abstract available.

PMID:
21168209
39.

Phase shift migration for imaging layered objects and objects immersed in water.

Olofsson T.

IEEE Trans Ultrason Ferroelectr Freq Control. 2010 Nov;57(11):2522-30. doi: 10.1109/TUFFC.2010.1718.

PMID:
21041139
40.

Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.

Järås M, Johnels P, Hansen N, Agerstam H, Tsapogas P, Rissler M, Lassen C, Olofsson T, Bjerrum OW, Richter J, Fioretos T.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16280-5. doi: 10.1073/pnas.1004408107. Epub 2010 Aug 30.

41.

Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.

Olofsson T, Englund M, Saxne T, Jöud A, Jacobsson LT, Geborek P, Allaire S, Petersson IF.

Ann Rheum Dis. 2010 Dec;69(12):2131-6. doi: 10.1136/ard.2009.127852. Epub 2010 Aug 6.

PMID:
20693274
42.

Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.

Agerstam H, Järås M, Andersson A, Johnels P, Hansen N, Lassen C, Rissler M, Gisselsson D, Olofsson T, Richter J, Fan X, Ehinger M, Fioretos T.

Blood. 2010 Sep 23;116(12):2103-11. doi: 10.1182/blood-2009-05-217182. Epub 2010 Jun 16.

43.

Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U.

Leukemia. 2010 May;24(5):992-1000. doi: 10.1038/leu.2010.33. Epub 2010 Mar 18.

PMID:
20237505
44.

Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.

Andersson A, Edén P, Olofsson T, Fioretos T.

BMC Med Genomics. 2010 Mar 8;3:6. doi: 10.1186/1755-8794-3-6.

45.

Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.

Kärrlander M, Lindberg N, Olofsson T, Kastemar M, Olsson AK, Uhrbom L.

PLoS One. 2009 Dec 31;4(12):e8536. doi: 10.1371/journal.pone.0008536.

46.

Short echo time MR spectroscopy of brain tumors: grading of cerebral gliomas by correlation analysis of normalized spectral amplitudes.

Weis J, Ring P, Olofsson T, Ortiz-Nieto F, Wikström J.

J Magn Reson Imaging. 2010 Jan;31(1):39-45. doi: 10.1002/jmri.21991.

PMID:
20027571
47.

Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006.

Thörn I, Forestier E, Thuresson B, Wasslavik C, Malec M, Li A, Lindström-Eriksson E, Botling J, Barbany G, Jacobsson S, Olofsson T, Porwit A, Sundström C, Rosenquist R.

Eur J Haematol. 2010 Feb 1;84(2):117-27. doi: 10.1111/j.1600-0609.2009.01374.x. Epub 2009 Nov 6.

PMID:
19895569
48.

Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.

Kahn R, Hellmark T, Leeb-Lundberg LM, Akbari N, Todiras M, Olofsson T, Wieslander J, Christensson A, Westman K, Bader M, Müller-Esterl W, Karpman D.

J Immunol. 2009 Jun 15;182(12):7906-15. doi: 10.4049/jimmunol.0803624.

49.

Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.

Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L.

Oncogene. 2009 Jun 11;28(23):2266-75. doi: 10.1038/onc.2009.76. Epub 2009 Apr 27.

PMID:
19421151
50.

Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array.

Nord H, Hartmann C, Andersson R, Menzel U, Pfeifer S, Piotrowski A, Bogdan A, Kloc W, Sandgren J, Olofsson T, Hesselager G, Blomquist E, Komorowski J, von Deimling A, Bruder CE, Dumanski JP, Díaz de Ståhl T.

Neuro Oncol. 2009 Dec;11(6):803-18. doi: 10.1215/15228517-2009-013.

Supplemental Content

Loading ...
Support Center